Northwest Bio Heading North, PRTK To Report Data In June, FLML Gets FDA Nod

Shares of Flamel Technologies (FLML) were up over 7% on Monday, following FDA approval of Akovaz, a drug administered parenterally as a pressor agent to address clinically important hypotension in surgical settings.

from RTT - Biotech http://ift.tt/1NRd2fl
via IFTTT